Gregory J. Moran

Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.

Haemophilus influenzae type b (Hib) causes serious invasive diseases among previously healthy children aged <5 years. Before the availability of conjugate vaccines in 1988, Hib was the most common cause of bacterial meningitis among preschool-aged children. Since 1993, the incidence of Hib invasive disease (defined as illness clinically compatible with invasive disease such as meningitis or sepsis, with isolation of the bacterium from a normally sterile site) among children aged <5 years has declined >95% in the United States. This report describes the continued decline of reported Hib invasive disease cases and underscores the need for investigation of Haemophilus influenzae (Hi) invasive disease cases.

Update on emerging infections: news from the Centers for Disease Control and Prevention.

Editor’s note: This article is part of a regular series on emerging infections from the Centers for Disease Control and Prevention (CDC) and the EMERGEncy ID NET, an emergency department–based and CDC-collaborative surveillance network. Important infectious disease public health information with relevance to emergency physicians is reported. The goal of this series is to advance knowledge about communicable diseases in emergency medicine and foster cooperation between the front line of clinical medicine and public health agencies.

Update on Emerging Infections: News from the Centers for Disease Control and Prevention: Tetanus Among Injecting-Drug Users—California, 1997

Abstract Editors note: This article is part of a regular series on emerging infections from the Centers for Disease Control and Prevention (CDC) and the EMERGEncy ID NET, an ED-based and CDC-collaborative surveillance network. Important public health information on infectious disease with relevance to emergency physicians is reported. The goal of this series is to advance knowledge about communicable diseases in emergency medicine, and foster cooperation between the front line of clinical medicine and public health agencies. [Talan DA, Moran GJ: Tetanus among injecting-drug users—California, 1997. Ann Emerg Med September 1998;32:385-386.]